Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study

Keyphrases

• Inflammation Markers 100%
• HIV Patients 100%
• Cerebrospinal Fluid 100%
• Axonal Damage 100%
• Retrospective Longitudinal Study 100%
• Soluble CD14 (sCD14) 100%
• Lipopolysaccharide 35%
• Microbial Translocation 29%
• Neopterin 23%
• Cognitive Impairment 17%
• Plasma Fluid 17%
• Inflammation 11%
• Monocyte Activation 11%
• HIV Infection 11%
• Central Nervous System Inflammation 11%
• Mild Forms 5%
• University Hospital 5%
• Regression Analysis 5%
• Sweden 5%
• Central Nervous System 5%
• Cell Count 5%
• Paired Samples 5%
• Chronic Inflammation 5%
• HIV RNA 5%
• Combined Antiretroviral Therapy (cART) 5%
• CD4+ 5%
• Cognitive Symptoms 5%
• Gothenburg 5%
• Untreated Patients 5%
• Neurofilament Light (NF-L) 5%
• Univariate Regression Analysis 5%
• Multivariate Regression Model 5%
• Colorimetric Assay 5%
• Minneapolis 5%
• Lonza 5%
• HIV-associated Neurocognitive Disorders 5%
• Cognitive Biomarkers 5%

Biochemistry, Genetics and Molecular Biology

• Cross Sectional Study 100%
• Human Immunodeficiency Virus 100%
• Liquid 100%
• CD14 100%
• Lipopolysaccharide 35%
• Neopterin 23%
• Monocyte 11%
• Cognition 5%
• RNA 5%
• CD4 Lymphocyte Count 5%
• Neurofilament 5%
• Light Chain 5%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• Cerebrospinal Fluid 100%
• CD14 100%
• Blood Plasma 47%
• Neopterin 23%
• Central Nervous System 17%
• Monocyte 11%
• Human Immunodeficiency Virus Infection 11%
• Cognition 5%
• ELISA 5%
• CD4 Lymphocyte Count 5%
• Neurofilament 5%
• Light Chain 5%